Figure 4.
![GATA2 IHC in adult AML. (A-D) Representative fields of GATA2 IHC in 3 different adult AML cases (3,3′-Diaminobenzidine [DAB] and hematoxylin; original magnification ×400). (E-F) Percent GATA2+ bone marrow blasts in acute leukemia subtypes (AMLs, n = 75; ALLs, n = 26; AULs, and n = 5). (G-H) Correlation between percent GATA2+ blasts and (G) neutropenia (n = 75) and (H) complex cytogenetics (n=74)) in AML. Error bars = SEM; ∗P < .05 and ∗∗∗P < .005.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/8/1/10.1182_bloodadvances.2023011554/2/blooda_adv-2023-011554-gr4.jpeg?Expires=1735806431&Signature=CClMKbFdenCNBOLmCABeIOMGaicxE5BG2oTIcD2d1uXavyRS8Wg4IjU42HAsqTP0GgjP0g9fkaFUKArBjiY~xtV3w3oF~ZCfZIDfx0P5iAwCNcYdeLQeBkJaGFZy8cV-oX6kX1Tu~bWqbuDNk7SlUW9KAfvrLVbGVmEujY6XA351u8zrhfZRjSuIvm7fK2BXAWMSdNWoKSKvIunezsVLlUEX9DmyQDtJYk-vc6I6BDE87Ys4L5-M-xNLJD3Gdg0oQvEhrKzO5OAzzggBb19lNS5HuYcfaYACAiBrvQU3560NGdCd12y1yisyo-3HTpHeDT5lASkK5M4oUyQenElDsA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
GATA2 IHC in adult AML. (A-D) Representative fields of GATA2 IHC in 3 different adult AML cases (3,3′-Diaminobenzidine [DAB] and hematoxylin; original magnification ×400). (E-F) Percent GATA2+ bone marrow blasts in acute leukemia subtypes (AMLs, n = 75; ALLs, n = 26; AULs, and n = 5). (G-H) Correlation between percent GATA2+ blasts and (G) neutropenia (n = 75) and (H) complex cytogenetics (n=74)) in AML. Error bars = SEM; ∗P < .05 and ∗∗∗P < .005.
